1 completed, 1 recruiting, 1 terminated. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 1, Recruiting 1, Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Total Knee Replacement: new trials by email Literature Review of Total Knee Replacement trials Research Report on Total Knee Replacement
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Suzetrigine in TKA Placebo, Suzetrigine - Total Knee Arthroplasty (TKA), Total Knee Arthroplasty \(TKA\) | Phase 3 | Recruiting | Hospital for Special Surgery, New York | 148 | 2026-10-15 | 2026-10-13 |
| Meloxicam for Pain Management After Total Joint Arthroplasty (TJA) IV meloxicam, Ketorolac - Total Knee Replacement, Total Hip Replacement | Phase 3 | Completed | University of Miami | 223 | 2022-05-01 | 2024-08-14 |
| Adductor Canal Block Ropivacaine injection, Saline Injection, Total Knee Arthroplasty - Osteoarthritis, Total Knee Replacement | Phase 2 / Phase 3 | Terminated | OrthoCarolina Research Institute, Inc. | 93 | 2020-10-09 | 2026-04-06 |
Agnosia (1) · Osteoarthritis (1) · Pain (1)
Arthritis (1) · Joint Diseases (1) · Musculoskeletal Diseases (1) · Nervous System Diseases (1) · Neurobehavioral Manifestations (1) · Neurologic Manifestations (1) · Pathological Conditions, Signs and Symptoms (1) · Perceptual Disorders (1) · Rheumatic Diseases (1) · Signs and Symptoms (1)
Arthroplasty, Replacement, Knee (1) · Ketorolac (1) · Meloxicam (1) · Ropivacaine (1) · Sodium Chloride (1)
Hospital for Special Surgery, New York (1) · OrthoCarolina Research Institute, Inc. (1) · University of Miami (1)
United States (3)
Alexandra Sideris, PhD (1) · Bryan D Springer, MD (1) · Meghan Kirskey, MD (1) · Victor H Hernandez, MD (1)